Page last updated: 2024-10-29

isoflurane and Morbid Obesity

isoflurane has been researched along with Morbid Obesity in 22 studies

Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Research Excerpts

ExcerptRelevanceReference
"For the treatment of bradycardia atropine sulfate should be adjusted at least to lean body weight in order to avoid paradoxical heart rate response in patients with obesity."5.42Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it. ( Carron, M; Veronese, S, 2015)
"Desflurane kinetics was determined by collecting end-tidal samples from first breaths at 1, 5, 10, 15, 20, 25 and 30 min."5.34Effect of morbid obesity on kinetic of desflurane: wash-in wash-out curves and recovery times. ( Albertin, A; Bergonzi, PC; Gonfalini, M; La Colla, G; La Colla, L; Pasculli, N; Poli, D; Ruggieri, F; Turi, S, 2007)
" In the patient described in this article, heart block occurred and the Q-Tc interval became prolonged after muscle relaxant reversal with neostigmine; both were considered to be related to the combination of agents used in the case, as well as to other predisposing factors such as morbid obesity."4.84Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report. ( Shields, JA, 2008)
"When desflurane was used, recovery was also faster."2.73Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used. ( Albertin, A; La Colla, G; La Colla, L; Mangano, A, 2007)
"This randomized prospective study with blinded postanesthesia care unit (PACU) observers compared the recovery profiles in morbidly obese patients who received sevoflurane or desflurane for maintenance of anesthesia in combination with a remifentanil target controlled infusion (TCI)."2.72Postoperative results after desflurane or sevoflurane combined with remifentanil in morbidly obese patients. ( De Baerdemaeker, LE; Den Blauwen, NM; Herregods, LL; Jacobs, S; Mortier, EP; Pattyn, P; Struys, MM, 2006)
"Overall, the incidence of postoperative nausea and vomiting and the use of antiemetics did not differ between the two anesthetic groups."2.71Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. ( Anthone, GJ; Kaufman, WA; Lumb, PD; Manz, IL; Strum, EM; Szenohradszki, J, 2004)
"Desflurane has a low fat-blood solubility coefficient and may be better suited in this population to achieve a rapid emergence; however, sevoflurane has favorable cardiorespiratory properties that might also prove advantageous in the morbidly obese (MO) patient."2.71Choice of volatile anesthetic for the morbidly obese patient: sevoflurane or desflurane. ( Arain, SR; Barth, CD; Ebert, TJ; Shankar, H, 2005)
"For the treatment of bradycardia atropine sulfate should be adjusted at least to lean body weight in order to avoid paradoxical heart rate response in patients with obesity."1.42Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it. ( Carron, M; Veronese, S, 2015)
"Desflurane kinetics was determined by collecting end-tidal samples from first breaths at 1, 5, 10, 15, 20, 25 and 30 min."1.34Effect of morbid obesity on kinetic of desflurane: wash-in wash-out curves and recovery times. ( Albertin, A; Bergonzi, PC; Gonfalini, M; La Colla, G; La Colla, L; Pasculli, N; Poli, D; Ruggieri, F; Turi, S, 2007)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.55)18.7374
1990's0 (0.00)18.2507
2000's17 (77.27)29.6817
2010's4 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Carron, M1
Veronese, S1
Nakagawa, Y1
Kinomoto, M1
Fujii, A1
Hara, Y1
Ozdogan, HK1
Cetinkunar, S1
Karateke, F1
Cetinalp, S1
Celik, M1
Ozyazici, S1
Bui, AH1
Marco, AP1
Yli-Hankala, A1
De Baerdemaeker, LE2
Struys, MM2
Jacobs, S2
Den Blauwen, NM2
Bossuyt, GR1
Pattyn, P2
Mortier, EP2
Hemmerling, TM1
Olivier, JF1
Casati, A3
Torri, G3
Strum, EM1
Szenohradszki, J1
Kaufman, WA1
Anthone, GJ1
Manz, IL1
Lumb, PD1
Arain, SR1
Barth, CD1
Shankar, H1
Ebert, TJ1
Feld, JM1
Hoffman, WE2
Stechert, MM1
Hoffman, IW1
Ananda, RC2
Herregods, LL1
Vallejo, MC1
Sah, N1
Phelps, AL1
O'Donnell, J1
Romeo, RC1
Feld, J1
Paisansathan, C1
Park, H1
La Colla, G2
La Colla, L2
Turi, S1
Poli, D1
Albertin, A3
Pasculli, N1
Bergonzi, PC1
Gonfalini, M1
Ruggieri, F1
Mangano, A1
Shields, JA1
Sollazzi, L1
Perilli, V1
Modesti, C1
Annetta, MG1
Ranieri, R1
Tacchino, RM1
Proietti, R1
Comotti, L2
Bignami, E2
Scarioni, M2
Paganelli, M1
Santorsola, R1
Strube, PJ1
Hulands, GH1
Halsey, MJ1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Continuous Femoral Nerve Block With Modulation of Depth of Anesthesia on Prognosis of Patients Receiving Total Knee Arthroplasty[NCT02576015]380 participants (Anticipated)Interventional2016-03-31Not yet recruiting
Opioid Free Versus Opioid Balanced Anesthesia in Middle Ear Surgery.[NCT03809949]Phase 460 participants (Actual)Interventional2019-01-16Completed
Influence of Dexmedetomidine and Lidocaine on Opioid Consumption, Cognitive Function and Incidence of Neuropathic Pain in Laparoscopic Intestine Resection[NCT02616523]Phase 460 participants (Actual)Interventional2014-07-31Completed
Comparison of Lidocaine, Dexmedetomidine and Ketamine in Multimodal Analgesia Management Following Sleeve Gastrectomy Surgery: A Randomized Double-Blind Trial[NCT04836819]78 participants (Actual)Interventional2021-04-08Completed
The Effect of Gabapentin on Acute Pain and PONV in Bariatric Surgical Patients[NCT00886236]62 participants (Actual)Interventional2008-02-29Completed
The Use of Dexmedetomidine as an Adjuvant for Perioperative Pain Management in Morbidly Obese Adolescents Undergoing Bariatric Surgery[NCT02880540]Phase 326 participants (Actual)Interventional2016-03-31Completed
The Quality of Recovery After General Anesthesia With Desflurane and Sevoflurane in Endoscopic Ureteral Lithotripsy[NCT04712162]60 participants (Actual)Interventional2019-11-19Completed
A Comparison of Cerebral Oximetry After Propofol-Based Total Intravenous Anesthesia and Sevoflurane Inhalation Anesthesia in Morbidly Obese Patients Undergoing LSG: a Prospective, Single-Blinded, Randomized, Parallel-Group Study.[NCT03946657]Phase 460 participants (Actual)Interventional2019-01-20Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Consumption of Fentanyl

consumption of fentanyl (mg) during the procedure (NCT02616523)
Timeframe: time of the operation

Interventionmg (Mean)
Dexmedetomidine41
Lidocaine50
Placebo58

Consumption of Piritramide

consumption of piritramide (mg) in the recovery room (NCT02616523)
Timeframe: one hour after the operation

Interventionmg (Mean)
Dexmedetomidine4.63
Lidocaine5.25
Placebo4.25

Neuropathic Pain (Pain Questionnaire) dn4

Pain questionnaire dn4 will be send to participants after two months of surgery to evaluate the neuropathic pain. There are minimum 0 points and maximum 10 points. If the score is 4 or higher then the pain is likely to be neuropathic pain. (NCT02616523)
Timeframe: two months after the surgery

Interventionunits on a scale (Mean)
Dexmedetomidine0.11
Lidocaine0.00
Placebo0.45

Evaluate Incidence of Respiratory Depression as Evidenced by Pulse Oximetry Data

(NCT00886236)
Timeframe: 48 hours

Intervention% oxygen saturation (Mean)
1 Preoperative Gabapentin Liquid93
2 Preoperative and Postoperative Gabapentin Liquid94
3 Preoperative and Postoperative Placebo Liquid95

Evaluate the Amount of Diluadid Given Postoperatively

The amount of intraoperative and postoperative opioids used will be collected and analyzed for the three different arms. (NCT00886236)
Timeframe: 120 hours

Interventionml (Mean)
1 Preoperative Gabapentin Liquid11.035
2 Preoperative and Postoperative Gabapentin Liquid8.7
3 Preoperative and Postoperative Placebo Liquid12.4

Number of Participants Who Experience Incidence of Postoperative Nausea.

(NCT00886236)
Timeframe: 120 hours

InterventionParticipants (Count of Participants)
1 Preoperative Gabapentin Liquid12
2 Preoperative and Postoperative Gabapentin Liquid11
3 Preoperative and Postoperative Placebo Liquid12

Pain Scores (Numerical Rating Scale 0-10) Using the Faces Pain Scale-Revised

"Average pain scores during the day of surgery using the FPS-R rates pain on a scale from 1-10, with 0 representing no pain and 10 very much pain. Each level accompanies a facial expression, ranging from content to distress." (NCT02880540)
Timeframe: From surgery until discharge from the hospital, an average of 48 hours.

InterventionUnits on a scale (Median)
Control Group5
Dexmedetomidine Treated3.4

Reviews

2 reviews available for isoflurane and Morbid Obesity

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report.
    AANA journal, 2008, Volume: 76, Issue:1

    Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalati

2008

Trials

11 trials available for isoflurane and Morbid Obesity

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Optimization of desflurane administration in morbidly obese patients: a comparison with sevoflurane using an 'inhalation bolus' technique.
    British journal of anaesthesia, 2003, Volume: 91, Issue:5

    Topics: Adult; Anesthesia Recovery Period; Anesthetics, Inhalation; Desflurane; Drug Administration Schedule

2003
Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study.
    Anesthesia and analgesia, 2004, Volume: 99, Issue:6

    Topics: Adult; Anesthesia Recovery Period; Anesthetics, Inhalation; Desflurane; Electroencephalography; Fema

2004
Choice of volatile anesthetic for the morbidly obese patient: sevoflurane or desflurane.
    Journal of clinical anesthesia, 2005, Volume: 17, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Anesthetics, Inhalation; Atracurium; Body Ma

2005
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery.
    Journal of clinical anesthesia, 2006, Volume: 18, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Analgesic

2006
Postoperative results after desflurane or sevoflurane combined with remifentanil in morbidly obese patients.
    Obesity surgery, 2006, Volume: 16, Issue:6

    Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Desflurane; Female; Gastroplasty; Humans;

2006
Desflurane versus sevoflurane for laparoscopic gastroplasty in morbidly obese patients.
    Journal of clinical anesthesia, 2007, Volume: 19, Issue:1

    Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthesia, Inhalation; Anesthetics, Inhalat

2007
Autonomic activity during dexmedetomidine or fentanyl infusion with desflurane anesthesia.
    Journal of clinical anesthesia, 2007, Volume: 19, Issue:1

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Analgesics, Opioid; Analysis of Variance; Anesthesia, Genera

2007
Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used.
    British journal of anaesthesia, 2007, Volume: 99, Issue:3

    Topics: Adult; Anesthesia Recovery Period; Anesthetics, Inhalation; Anthropometry; Desflurane; Double-Blind

2007
Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients.
    Journal of clinical anesthesia, 2001, Volume: 13, Issue:8

    Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthetics, Inhalation; Blood Pressure; Dou

2001
Wash-in and wash-out curves of sevoflurane and isoflurane in morbidly obese patients.
    Minerva anestesiologica, 2002, Volume: 68, Issue:6

    Topics: Adult; Anesthesia; Anesthetics, Inhalation; Double-Blind Method; Female; Humans; Isoflurane; Male; M

2002

Other Studies

10 other studies available for isoflurane and Morbid Obesity

ArticleYear
Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it.
    BMJ case reports, 2015, Jan-29, Volume: 2015

    Topics: Aged; Anesthesia, General; Anti-Arrhythmia Agents; Atrioventricular Block; Atropine; Bradycardia; De

2015
[Desflurane Anesthesia in a Morbidly Obese Patient with Severe Obstructive Sleep Apnea].
    Masui. The Japanese journal of anesthesiology, 2015, Volume: 64, Issue:4

    Topics: Accidents, Traffic; Adult; Anesthesia, General; Anesthetics, Inhalation; Desflurane; Femoral Fractur

2015
The effects of sevoflurane and desflurane on the hemodynamics and respiratory functions in laparoscopic sleeve gastrectomy.
    Journal of clinical anesthesia, 2016, Volume: 35

    Topics: Adult; Anesthetics, Inhalation; Cohort Studies; Desflurane; Female; Gastrectomy; Hemodynamics; Human

2016
Peripheral nerve blockade in a patient with Charcot-Marie-Tooth disease.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2008, Volume: 55, Issue:10

    Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine; Charcot-Marie-To

2008
Will enough isoflurane during surgery replace morphine after surgery?
    Acta anaesthesiologica Scandinavica, 2003, Volume: 47, Issue:7

    Topics: Analgesics, Opioid; Anesthetics, Inhalation; Electroencephalography; Humans; Intraoperative Care; Is

2003
Desflurane might not be the optimal volatile anaesthetic in morbidly obese patients.
    British journal of anaesthesia, 2004, Volume: 92, Issue:3

    Topics: Anesthetics, Inhalation; Desflurane; Humans; Isoflurane; Obesity, Morbid; Research Design

2004
Cardiovascular stability during inhalational anaesthesia in morbidly obese patients: which is better, sevoflurane or desflurane?
    British journal of anaesthesia, 2004, Volume: 93, Issue:1

    Topics: Anesthetics, Inhalation; Desflurane; Hemodynamics; Humans; Isoflurane; Methyl Ethers; Obesity, Morbi

2004
Effect of morbid obesity on kinetic of desflurane: wash-in wash-out curves and recovery times.
    Minerva anestesiologica, 2007, Volume: 73, Issue:5

    Topics: Adult; Aged; Anesthesia, Inhalation; Anesthetics, Inhalation; Anesthetics, Intravenous; Desflurane;

2007
Volatile anesthesia in bariatric surgery.
    Obesity surgery, 2001, Volume: 11, Issue:5

    Topics: Adult; Anesthesia Recovery Period; Anesthetics, Inhalation; Biliopancreatic Diversion; Heart Rate; H

2001
Serum fluoride levels in morbidly obese patients: enflurane compared with isoflurane anaesthesia.
    Anaesthesia, 1987, Volume: 42, Issue:7

    Topics: Adult; Anesthesia, Inhalation; Enflurane; Female; Fluorides; Humans; Isoflurane; Obesity, Morbid; Ti

1987